Cargando…
Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
Radical nephroureterectomy (RNU) remains the gold-standard in the treatment of invasive urothelial cancers of the upper tract (>pT2). However, there are stage-related, postoperative recurrence and cancer-specific death rates that are unacceptably high. Multimodality treatment regimens including n...
Autor principal: | Kaag, Matthew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475667/ https://www.ncbi.nlm.nih.gov/pubmed/32944552 http://dx.doi.org/10.21037/tau.2020.03.48 |
Ejemplares similares
-
Outcomes of endoscopic management of upper tract urothelial carcinoma
por: Knoedler, John J.
Publicado: (2020) -
Endoscopic management of upper tract urothelial carcinoma—tips and tricks
por: Shvero, Asaf, et al.
Publicado: (2020) -
An editorial comment for the special series “Upper-Tract Urothelial Carcinoma: Current State and Future Directions”
por: Knoedler, John J., et al.
Publicado: (2020) -
Epidemiology, clinical presentation, and evaluation of upper-tract urothelial carcinoma
por: Petros, Firas G.
Publicado: (2020) -
Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)